e-Rx and EHR Master Class
Leverage the Power of e-RX and EHR for Promotional Effectiveness
e-Rx and EHR Master Class | October 21-22, 2015 | San Francisco, CA

Wednesday, March 28, 2007

Dong-A PharmTech: New Erectile Dysfunction Drug

This just came into my email inbox:

"Dong-A PharmTech Co., Ltd. [a Korean drug company] announced today that it has completed a 340 patient phase 2b 'at-home' clinical study for udenafil, its new long acting (12 hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction (ED)."

See press release.

Does anyone else find this amusing?


  1. Anonymous6:38 AM

    Good grief Mr Mack!

    How puerile can your humor get?

    Please cease and desist!!

    Kind regards


  2. Anonymous1:55 PM

    I think you have been reading PharmaGiles again...


Related Posts Plugin for WordPress, Blogger...